Lack of association between platelet glycoprotein IIb/IIIa receptor P1(A) polymorphism and coronary artery disease or carotid intima-media thickness

Thrombosis Research

Volumn 89, Issue 2, 1998, Pages 85-89

  Garg, Uttam C ^a   Arnett, Donna K ^b   Folsom, Aaron R ^b   Province, Michael A ^c   Williams, Roger R ^d   Eckfeldt, John H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Carotid intima media thickness; Coronary heart disease; IIb IIIa polymorphism; Platelet receptors

Indexed keywords

FIBRINOGEN RECEPTOR;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THICKNESS;

ADULT; ANTIGENS, HUMAN PLATELET; BINDING SITES; BLOOD PLATELETS; CAROTID ARTERIES; CORONARY DISEASE; DNA; DNA PRIMERS; FIBRINOGEN; HUMANS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VON WILLEBRAND FACTOR;

EID: 0032518209     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00295-8     Document Type: Article

References (14)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;310-318.
2. Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 332:1995;1553-1559.
3. Hantgan R.R., Hindriks G., Taylor R.G., Sixma J.J., de Groot P.G. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are involved in platelet adhesion to fibrin in flowing whole blood. Blood. 76:1990;345-363.
4. Jang Y., Lincoff A.M., Plow E.F., Topol E.J. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 24:1994;1591-1601.
5. Parise L.V., Steiner B., Nannizzi L., Criss A.B., Phillips D.R. Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen. Biochemical J. 289:1993;45-51.
6. The EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
7. Lefkovits J., Ivanhoe R.J., Califf R.M., Bergelson B.A., Anderson K.M., Stoner G.L., Weisman H.F., Topol E.J. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators. Am J Cardiol. 77:1996;1045-1051.
8. Matsuno H., Stassen J.M., Vermtlen J., Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 90:1994;2203-2206.
9. Weiss E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C., Weiss J.L., Gerstenblith G., Goldschmidt-Clermont P.J. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 334:1996;1090-1094.
10. A polymorphism and myocardial infarction. N Engl J Med. 335:1996;1071-1072.
11. A polymorphism and myocardial infarction. N Engl J Med. 335:1996;1072-1073.
12. Higgins M., Province M., Heiss G., Eckfeldt J., Ellison R.C., Folsom A., Rao D.C., Sprafka J.M., Williams R., for the NHLBI Family Heart Study Investigators The NHLBI Family Heart Study. objectives and design Am J Epidemiol. 143(12):1996;1219-1228.
13. Djaffar I., Caen J.P., Rosa J.P. A large alteration in the human platelet glycoprotein IIIa (integrin beta 3) gene associated with Glanzmann's thrombasthenia. Hum Mol Genetics. 2:1993;2183-2185.
14. Pober M., Kyrle P.A., Panzer S. Genotyping provides a reliable tool for the determination of the platelet antigen system HPA-1 in Glanzmann's thrombasthenia. Br J Haematol. 85:1993;112-115.